CONMED Corporation Declares Quarterly Cash Dividend
CNMD Stock | USD 70.36 1.18 1.71% |
About 68 percent of all CONMED's shareholders are curious in acquiring. The analysis of overall sentiment of trading CONMED stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with CONMED's historical and current headlines, can help investors time the market. In addition, many technical investors use CONMED stock news signals to limit their universe of possible portfolio assets.
CONMED |
CONMED Corporation made an announcement in a recent 8-K filing on December 9, 2024. The Board of Directors at CONMED declared a quarterly cash dividend of 0.20 per share. This dividend is set to be payable on January 3, 2025, to all shareholders of record as of December 20, 2024. The declaration comes
Read at thelincolnianonline.com
CONMED Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards CONMED can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CONMED Fundamental Analysis
We analyze CONMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CONMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CONMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
CONMED is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
CONMED Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CONMED stock to make a market-neutral strategy. Peer analysis of CONMED could also be used in its relative valuation, which is a method of valuing CONMED by comparing valuation metrics with similar companies.
Peers
CONMED Related Equities
GKOS | Glaukos Corp | 1.93 | ||||
IRTC | IRhythm Technologies | 0.80 | ||||
ITGR | Integer Holdings | 0.80 | ||||
ANIK | Anika Therapeutics | 0.62 | ||||
GMED | Globus Medical | 0.45 | ||||
SRDX | SurModics | 0.40 | ||||
STE | STERIS Plc | 0.33 | ||||
OFIX | Orthofix Medical | 0.06 | ||||
KIDS | Orthopediatrics Corp | 0.18 | ||||
LIVN | LivaNova PLC | 0.51 | ||||
SIBN | Si Bone | 0.68 | ||||
LUNG | Pulmonx Corp | 1.60 | ||||
SGHT | Sight Sciences | 1.68 | ||||
ATEC | Alphatec Holdings | 2.46 |
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |